IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies.IDRx is headquartered in Plymouth, Massachusetts and was founded in 2022.

Biotechnology

IDRx

IDRx's headquarters in Plymouth, MA, United States

Jorge Conde

The Leadership Team at IDRx is responsible for strategic decision-making and guiding the company's vision in developing precision combination therapies for cancer care. This team, composed of experienced professionals across various disciplines, including clinical pharmacology, product development, and biostatistics, collaborates to advance clinical programs, ensure regulatory compliance, and drive innovation in oncology treatments. Their collective expertise helps shape IDRx's research direction and operational strategies to maximize therapeutic impact and patient outcomes.

Leadership Team

The Clinical and Pharmaceutical Development team at IDRx is responsible for overseeing the design, execution, and management of clinical trials and pharmaceutical development processes. This multidisciplinary team collaborates to ensure the effective integration of drug metabolism, pharmacokinetics, clinical operations, and biostatistics, aiming to advance innovative precision combination therapies that enhance cancer treatment outcomes.

IDRx

Org chart

Teams

Leadership Team

Clinical and Pharmaceutical Development

Offices

IDRx

Org chart

Teams

Leadership Team

Clinical and Pharmaceutical Development

Offices

Related companies